US Patent 8293228 Variant form of urate oxidase and use thereof
Patent 8293228 was granted and assigned to Savient Pharmaceuticals, Inc. on October, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jacob Hartman0
Simona Mendelovitz0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08293228 Variant form of urate oxidase and use thereof US Patent 8293228 Variant form of urate oxidase and use thereof
Infobox
Patent Number
082932280
Patent Number
82932280
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
082932280
Date of Patent
October 23, 2012
0Patent Application Number
134521510
Date Filed
April 20, 2012
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08293228 Variant form of urate oxidase and use thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08293228
Date of patent
October 23, 2012
Patent application number
13452151
Date Filed
April 20, 2012
Patent primary examiner
Find more entities like US Patent 8293228 Variant form of urate oxidase and use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.